GlassScriptPhysician profile
Ella Wilson
NPI 1548284870
$875.45
in general payments reported to CMS, 2019-2025
15 companies · $70.08 in 2025
The $70.08 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.51 · 2022: $238 · 2023: $299 · 2024: $225 · 2025: $70.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.50 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $194.92 | 2021-2023 | Mounjaro |
| Vanda Pharmaceuticals INC. | $146.41 | 2022-2023 | Hetlioz |
| Ironwood Pharmaceuticals, INC | $86.28 | 2022-2024 | Linzess |
| Indivior INC. | $69.92 | 2024 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.60 | 2023-2024 | Xifaxan, Trulance |
| Exact Sciences Corporation | $53.25 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $50.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.12 | 2023 | |
| Ardelyx, INC. | $47.29 | 2024 | Ibsrela |
| Sanofi Pasteur INC. | $34.74 | 2024-2025 | |
| Corium, LLC | $18.49 | 2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $17.92 | 2024 | Abilify Maintena |
| Merck Sharp & Dohme LLC | $15.93 | 2021 | |
| Gilead Sciences, INC. | $15.83 | 2023 | Epclusa |
| Astellas Pharma US INC | $13.22 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ella Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.